Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2021 Preclinical data presented at AACR highlight four precision therapies with first- or best-in-class potential IND application cleared by FDA for BLU-945, a triple-mutant EGFR inhibitor for EGFR-driven lung cancer Nominated BLU-222, a selective and potent CDK2 inhibitor development candidate, for cyclin E-aberrant cancers Blueprint Medicines to host investor conference call and webcast on Monday, April 12 at 8:00 a.m. ET
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., April 10, 2021 /PRNewswire/ Blueprint Medicines Corporation (NASDAQ: BPMC) today announced data from multiple poster presentations highlighting the breadth of the company s precision therapy pipeline at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021. Collectively, the presentations, including foundational preclin
Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Surface Oncology Presents Promising Preclinical Data for Lead Immunotherapy Product Candidates at the American Association for Cancer Research Annual Meeting
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Heatherdale Appoints Marilyne Lacasse, P Geo as Vice-President, Exploration
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Heatherdale Resources Ltd.: Heatherdale Appoints Marilyne Lacasse, P.Geo as Vice-President, Exploration
Heatherdale or the
Company ) (TSXV:HTR) is pleased to announce that Ms. Marilyne Lacasse, P.Geo has been appointed Vice-President, Exploration for the Company, effective April 1, 2020. Ms. Lacasse is considered one of the most talented, young exploration geologists in the Pacific Northwest and we are very grateful for her acceptance of the position of Vice President, Exploration for our Company. said Rob McLeod, President and CEO of Heatherdale.
Her experience and strength in working safely in challenging geological terranes, track record for discovering mineralization and incorporation of new and innovative technologies are impressive. Her abilities and enthusiasm for exploration anywhere from advanced-stage resource expansion to greenfields project has enabled her to attract additional technical talent in both Alaska and Canada.